FABP1 and COVID-19: When testing urine for L-FABP, we initially performed urine nucleic acid amplification tests (NAAT) on 200 COVID-19-positive patients to evaluate the possibility of environmental contamination by COVID-19 urine, but all 200 mild to severe cases were negative, soon after diagnosis.